Background: The aim of the study was to compare the TNM classification with 2-[F]FDG PE T biological parameters of primary tumor in patients with NSCLC.
Materials And Methods: Retrospective analysis was performed on a group of 79 newly diagnosed NSCLC patients. PET scans were acquired on Gemini TF PET/CT scanner 60-70 min after injection of 2-[F]FDG with the mean activity of 364 ± 75 MBq, with the area being examined from the vertex to mid-thigh. The reconstructed PET images were evaluated using MIM 7.0 Software for SUV, MTV and TLG values.
Results: The analysis of the cancer stage according to TNM 8 edition showed stage IA2 in 8 patients, stage IA3 - 6 patients, stage IB - 4 patients, IIA - 3 patients, 15 patients with stage IIB, stage IIIA - 17 patients, IIIB - 5, IIIC - 5, IVA in 7 patients and stage IVB in 9 patients. The lowest TLG values of primary tumor were observed in stage IA2 (11.31 ± 15.27) and the highest in stage IIIC (1003.20 ± 953.59). The lowest value of primary tumor in SUV and MTV were found in stage IA2 (6.8 ± 3.8 and 1.37 ± 0.42, respectively), while the highest SUV of primary tumor was found in stage IIA (13.4 ± 11.4) and MTV in stage IIIC (108.15 ± 127.24).
Conclusion: TNM stages are characterized by different primary tumor 2-[F]FDG PET parameters, which might complement patient outcome.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281901 | PMC |
http://dx.doi.org/10.5603/RPOR.a2021.0072 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!